Nutriband, Inc. (NTRB)
7.28
-0.08
(-1.09%)
USD |
NASDAQ |
Oct 02, 16:00
7.50
+0.22
(+3.02%)
After-Hours: 20:00
Nutriband Enterprise Value : 85.29M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 85.29M |
| October 01, 2026 | 86.27M |
| September 30, 2026 | 88.21M |
| September 29, 2026 | 97.09M |
| September 28, 2026 | 96.84M |
| September 25, 2026 | 94.05M |
| September 24, 2026 | 106.08M |
| September 23, 2026 | 86.15M |
| September 22, 2026 | 78.97M |
| September 21, 2026 | 91.25M |
| September 18, 2026 | 95.63M |
| September 17, 2026 | 89.79M |
| September 16, 2026 | 82.38M |
| September 15, 2026 | 79.70M |
| September 14, 2026 | 80.98M |
| September 11, 2026 | 81.40M |
| September 10, 2026 | 70.71M |
| September 09, 2026 | 67.30M |
| September 08, 2026 | 70.95M |
| September 04, 2026 | 69.37M |
| September 03, 2026 | 65.24M |
| September 02, 2026 | 53.93M |
| September 01, 2026 | 49.62M |
| August 31, 2026 | 49.88M |
| August 28, 2026 | 51.02M |
| Date | Value |
|---|---|
| August 27, 2026 | 52.96M |
| August 26, 2026 | 51.50M |
| August 25, 2026 | 55.51M |
| August 24, 2026 | 58.92M |
| August 21, 2026 | 53.52M |
| August 20, 2026 | 43.18M |
| August 19, 2026 | 39.95M |
| August 18, 2026 | 38.74M |
| August 17, 2026 | 36.06M |
| August 14, 2026 | 36.91M |
| August 13, 2026 | 35.58M |
| August 12, 2026 | 34.18M |
| August 11, 2026 | 35.46M |
| August 10, 2026 | 34.97M |
| August 07, 2026 | 34.61M |
| August 06, 2026 | 32.24M |
| August 05, 2026 | 31.81M |
| August 04, 2026 | 31.44M |
| August 03, 2026 | 30.96M |
| July 31, 2026 | 31.44M |
| July 30, 2026 | 31.60M |
| July 29, 2026 | 31.24M |
| July 28, 2026 | 32.15M |
| July 27, 2026 | 32.45M |
| July 24, 2026 | 32.45M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ANI Pharmaceuticals, Inc. | 1.893B |
| Corcept Therapeutics, Inc. | 12.24B |
| Veru, Inc. | 19.69M |
| Johnson & Johnson | 644.86B |
| Eli Lilly & Co. | 1.122T |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.8806M |
| Revenue (Quarterly) | 0.4375M |
| Total Expenses (Quarterly) | 1.318M |
| EPS Diluted (Quarterly) | -0.0724 |
| Gross Profit Margin (Quarterly) | 40.73% |
| Profit Margin (Quarterly) | -201.3% |
| Earnings Yield | -7.90% |
| Normalized Earnings Yield | -7.904 |